2030년까지 북미 과색소침착 장애 치료 시장 전망 - 지역 분석 - 치료 유형(화장품, 광선 또는 레이저 치료, 미세각질술, 화학 필링, 극저온 치료 및 기타), 상태(간반, 태양성 흑자, 염증 후 과색소침착 및 기타) 및 최종 사용자(병원, 피부과 센터 및 기타)
간반 유병률 증가로 북미 과색소침착 장애 치료 시장이 활성화됨
가장 우세한 과색소침착 상태 중 하나인 간반은 얼굴, 특히 턱, 윗입술, 코, 이마, 뺨에 테두리가 있는 대칭적인 밝은 색에서 어두운 진흙빛 갈색 반점이 특징입니다. 여성과 피부색이 어두운 사람들에게 흔히 나타납니다. 간반에는 광대, 하악골, 안면 중심의 임상적 특징이 흔합니다. 일광 노출, 호르몬 변화, 임신, 유전적 요인, 화장품, 약물은 모두 간반 발병과 관련이 있습니다. 다양한 연구에 따르면 일반 인구의 간반 유병률은 1%에서 50% 사이인 것으로 추정됩니다. 간반 환자의 55~64%가 동일한 질환의 가족력이 있는 것으로 보고되었습니다. 게다가 동아시아 및 히스패닉계 개인과 피츠패트릭 피부 광형(IV~VI)이 높은 환자에서 유병률이 더 높은 것으로 보고되었습니다. 또한 강렬한 자외선을 받는 지역에 거주하는 개인에서도 유병률이 더 높습니다.
임신은 간반의 또 다른 흔한 원인입니다. 이 질환은 경구 피임약과 호르몬을 복용하는 여성에게도 영향을 미칩니다. 에스트로겐, 프로게스테론 및 멜라닌 세포 자극 호르몬 수치는 일반적으로 임신 3분기에 상승하는데, 이것이 요인일 수 있습니다. 2023년 8월 국립 생명공학 정보 센터(NCBI)에 따르면 간반은 생식 연령에 더 흔하며 사춘기 이전에는 거의 발생하지 않습니다. 영어: 이 상태는 임산부의 15~50%에서 발생하며, 유병률은 지역마다 인구에 따라 1.5%~33%입니다. 따라서 간반 유병률의 급증은 과색소 침착 치료에 대한 수요를 유발합니다.
북미 과색소 침착 장애 치료 시장 개요
북미의 과색소 침착 장애 치료 시장은 미국, 캐나다, 멕시코로 세분화됩니다. 미국은 2023년에 북미 과색소 침착 장애 치료 시장 점유율이 가장 높았습니다. Skin of Color Update 2024(피부과 컨퍼런스)에 따르면, 미국의 인구 통계는 미국의 히스패닉계, 아시아계 인구, 아프리카계의 국제적 이주로 인해 민족적, 인종적 다양성이 증가함에 따라 진화하고 있으며, 이는 2050년경에 피츠패트릭 III, IV, V, VI 피부 유형의 개인으로 소수에서 다수로 전환될 가능성이 높습니다. 특히, 히스패닉 인구는 미국에서 가장 빠르게 성장하는 인구 집단 중 하나가 될 것으로 예상되며, 2014년 5,500만 명에서 2060년 1억 1,900만 명으로 증가할 것으로 추산됩니다. 어두운 피부 유형은 과색소 침착 장애에 더 취약합니다.
미국에서 미용 시술의 수는 지난 10년 동안 크게 증가했습니다. 국제성형외과학회(ISAPS)에 따르면, 비외과적 미용 시술의 수는 2020년 대비 2021년에 전 세계적으로 19.9% 증가했습니다. 강력한 펄스 광(IPL) 치료는 최소 침습적 미용 시술 중 상위 5개에 속하며, 2020년에 미국에서 약 827,000건의 IPL 시술이 수행되었습니다. 따라서 비침습적 시술의 기술적 발전은 미국 내 과색소 침착 장애 치료 시장에 더욱 큰 혜택을 줄 가능성이 높습니다. 2023년 3월, 미국 식품의약국(FDA)은 Candela Corporation의 PicoWay 레이저를 카페오레, 간반, 흑자, 오타모반 치료에 승인했습니다. 이전에 이 레이저 시스템은 양성 색소 병변, 여드름 흉터, 주름, 문신 제거 등의 치료에 승인되었습니다.
따라서 인종적 다양성 증가와 화장품, 케미컬 필링, 극저온 요법, 광선 또는 레이저 요법과 같은 비침습적 의료 미용 시술의 개발과 같은 요인이 미국에서 과색소 침착 장애 치료 시장 성장에 기여합니다.
북미 과색소 침착 장애 치료 시장 수익 및 2030년 예측(백만 달러)
북미 과색소 침착 장애 치료 시장 세분화
북미 과색소 침착 장애 치료 시장은 치료 유형, 상태, 최종 사용자 및 국가로 분류됩니다.
치료 유형에 따라 북미 과색소 침착 장애 치료 시장은 화장품, 광선 또는 레이저 치료, 미세각질술, 화학적 필링, 극저온 치료 등으로 세분화됩니다. 화장품 부문은 2022년에 가장 큰 시장 점유율을 차지했습니다.
상태에 따라 북미 과색소 침착 장애 치료 시장은 간반, 태양성 흑자, 염증 후 과색소 침착 등으로 세분화됩니다. 간반 부문은 2022년에 가장 큰 시장 점유율을 차지했습니다.
최종 사용자에 따라 북미 과색소 침착 장애 치료 시장은 병원, 피부과 센터 등으로 세분화됩니다. 병원 부문은 2022년에 가장 큰 시장 점유율을 차지했습니다.
국가별로 북미 과색소 침착 장애 치료 시장은 미국, 캐나다, 멕시코로 세분화됩니다. 미국은 2022년에 북미 과색소침착 장애 치료 시장 점유율을 장악했습니다.
AbbVie Inc, Bayer AG, Galderma SA, L\'OREAL SA, Lutronic Co Ltd, Obagi Cosmeceuticals LLC, Vivier Pharma Inc는 북미 과색소침착 장애 치료 시장에서 활동하는 주요 회사 중 일부입니다.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Hyperpigmentation Disorder Treatment Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Rise in Prevalence of Melasma
4.1.2 Increasing Number of Hyperpigmentation Disorder Awareness Programs
4.2 Market Restraints
4.2.1 High Cost of Treatments
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
4.4.1 Use of Ablative Lasers
4.4.2 Novel Products Based on PATH-3 Technology
4.5 Impact of Drivers and Restraints:
5. Hyperpigmentation Disorder Treatment Market - North America Analysis
5.1 North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2020-2030
6. North America Hyperpigmentation Disorder Treatment Market Analysis - by Treatment Type
6.1 Cosmeceutical
6.1.1 Overview
6.1.2 Cosmeceutical: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Light or Laser Therapy
6.2.1 Overview
6.2.2 Light or Laser Therapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Microdermabrasion
6.3.1 Overview
6.3.2 Microdermabrasion: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Chemical Peels
6.4.1 Overview
6.4.2 Chemical Peels: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cryotherapy
6.5.1 Overview
6.5.2 Cryotherapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Others
6.6.1 Overview
6.6.2 Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7. North America Hyperpigmentation Disorder Treatment Market Analysis - by Condition
7.1 Melasma
7.1.1 Overview
7.1.2 Melasma: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Solar Lentigines
7.2.1 Overview
7.2.2 Solar Lentigines: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Post-inflammatory Hyperpigmentation
7.3.1 Overview
7.3.2 Post-inflammatory Hyperpigmentation: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Hyperpigmentation Disorder Treatment Market Analysis - by End User
8.1 Hospitals
8.1.1 Overview
8.1.2 Hospitals: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Dermatology Centers
8.2.1 Overview
8.2.2 Dermatology Centers: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Hyperpigmentation Disorder Treatment Market - Country Analysis
9.1 North America Hyperpigmentation Disorder Treatment Market
9.1.1 North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
9.1.1.1 North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
9.1.1.2 US
9.1.1.3 US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.1 US: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.3.2 US: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.3.3 US: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.4 Canada
9.1.1.5 Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.5.1 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.5.2 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.5.3 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.6 Mexico
9.1.1.7 Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.7.1 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.7.2 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.7.3 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
10. Hyperpigmentation Disorder Treatment Market - Industry Landscape
10.1 Overview
10.2 Growth Strategies in Hyperpigmentation Disorder Treatment Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 AbbVie Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Galderma SA
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Obagi Cosmeceuticals LLC
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Bayer AG
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Lutronic Co Ltd
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 L'OREAL S.A.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Pierre Fabre SA
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Vivier Pharma Inc
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
List of Tables
Table 1. North America Hyperpigmentation Disorder Treatment Market Segmentation
Table 2. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 3. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 4. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 5. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 6. Number of Laser-Based Nonsurgical Procedures Performed, 2020
Table 7. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 8. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 9. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 10. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 11. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 12. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 13. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 14. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 15. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 16. Recent Organic Growth Strategies in Hyperpigmentation Disorder Treatment Market
Table 17. Recent Inorganic Growth Strategies in the Hyperpigmentation Disorder Treatment Market
Table 18. Glossary of Terms, Hyperpigmentation Disorder Treatment Market
List of Figures
Figure 1. North America Hyperpigmentation Disorder Treatment Market Segmentation, by Country
Figure 2. North America Hyperpigmentation Disorder Treatment Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2022-2030
Figure 5. North America Hyperpigmentation Disorder Treatment Market Share (%) - by Treatment Type (2022 and 2030)
Figure 6. Cosmeceutical: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Light or Laser Therapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Microdermabrasion: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Chemical Peels: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Cryotherapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Hyperpigmentation Disorder Treatment Market Share (%) - by Condition (2022 and 2030)
Figure 13. Melasma: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solar Lentigines: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Post-inflammatory Hyperpigmentation: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. North America Hyperpigmentation Disorder Treatment Market Share (%) - by End User (2022 and 2030)
Figure 18. Hospitals: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Dermatology Centers: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America Hyperpigmentation Disorder Treatment Market, By Key Country - Revenue (2022) (US$ Million)
Figure 22. North America Hyperpigmentation Disorder Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 23. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Growth Strategies in Hyperpigmentation Disorder Treatment Market
- AbbVie Inc
- Bayer AG
- Galderma SA
- L'OREAL S.A.
- Lutronic Co Ltd
- Obagi Cosmeceuticals LLC
- Vivier Pharma Inc
- Pierre Fabre Group
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America hyperpigmentation disorder treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America hyperpigmentation disorder treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America hyperpigmentation disorder treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.